Hahyun Park Selected Research

beta-thujone (thujone)

1/2021	Therapeutic potential of α,β-thujone through metabolic reprogramming and caspase-dependent apoptosis in ovarian cancer cells.
1/2020	α,β-Thujone suppresses human placental choriocarcinoma cells via metabolic disruption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hahyun Park Research Topics

Disease

4	Inflammation (Inflammations) 09/2021 - 06/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 08/2021 - 01/2020
3	Edema (Dropsy) 02/2021 - 12/2019
3	Neoplasms (Cancer) 01/2021 - 06/2019
1	Cardiotoxicity 11/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Vascular Malformations 02/2020
1	Choriocarcinoma 01/2020
1	Parasitic Diseases (Parasitic Disease) 09/2019
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018

Drug/Important Bio-Agent (IBA)

2	CalciumIBA 08/2021 - 01/2020
2	beta-thujone (thujone)IBA 01/2021 - 01/2020
2	CaspasesIBA 01/2021 - 01/2020
2	Biological ProductsIBA 09/2019 - 06/2019
2	AnthelminticsIBA 09/2019 - 06/2019
1	dinitramineIBA 11/2021
1	EstersIBA 09/2021
1	Diflubenzuron (Dimilin)IBA 08/2021
1	aclonifenIBA 06/2021
1	HerbicidesIBA 06/2021
1	benfuresateIBA 02/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	haloxyfop-p-methylIBA 07/2020
1	bifenthrinIBA 02/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	etoxazoleIBA 12/2019
1	FenbendazoleIBA 09/2019
1	benzimidazoleIBA 09/2019
1	oxibendazoleIBA 06/2019
1	myricetinIBA 01/2018
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2018
1	AntioxidantsIBA 01/2018